Search
shopping
Search
Menu

Goal and Learning Outcomes

The goal of this diabetic foot ulcer continuing education program is to provide physicians, nurses, dietitians, imaging technologists, and physical therapists with information regarding the development, prevention, and care of diabetic wounds. After studying the information presented here, you will be able to:
  • Identify three components of diabetic peripheral neuropathy and explain how they may lead to development of a diabetic foot ulcer
  • Identify strategies for ulcer prevention
  • Discuss critical elements of the physical examination that identify patients at risk for
  • diabetic foot ulcers
  • Illustrate diagnostic and management options for infected or osteomyelitic diabetic foot ulcers
  • Describe principles of offloading, optimal wound care, and adjunct therapies in managing diabetic foot ulcers
  • Define barriers to effective care implementation for better disease management

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.